Class of medication: Cancer medications, PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors.
Active ingredient: Olaparib.
Uses:
Maintenance therapy for various types of advanced ovarian cancer.
Treatment of early and metastatic breast cancer.
Treatment of prostate cancer.
Metastatic pancreatic cancer.
Mechanism of action:
Inhibits the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells.
Prevents cancer cells from repairing their DNA, leading to cell death.
Important information:
Not recommended if you are allergic to the active compound and other ingredients of the medicine.
Consult your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing.
Blood tests will be conducted before and every month during treatment.
Inform your healthcare provider about all the medicines you are taking, including prescription, over-the-counter drugs, vitamins, and supplements.
Not advised to use while pregnant or breastfeeding.
Men are not advised to donate sperm for at least 3 months after treatment is finished.
Storage:
Store Ibyra 150mg Tablet in the original package at room temperature (20°C to 25°C).
Keep it out of reach from children.
How to consume:
The medicine will be prescribed to you by a healthcare professional in a hospital setting.
Available as a tablet to be taken with or without food, as directed by your healthcare provider.
The dose will be decided by your healthcare professional based on your conditions.
Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water.
Take the Ibyra 150mg Tablet at the same time every day.
Safety advices:
Pregnancy: It is not recommended to take Ibyra 150mg Tablet during pregnancy as it may harm your unborn baby.
Breastfeeding: It is unknown whether Ibyra 150mg Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy.
Lungs: Consult your doctor if you have any lung diseases before starting the treatment.
Liver: It is unknown whether Ibyra 150mg Tablet is safe in individuals with liver disorders.
Alcohol: It is unknown whether consuming alcohol interacts with the Ibyra 150mg Tablet. Please consult your doctor for more advice.
Driving: Ibyra 150mg Tablet may have an impact on your ability to operate machinery and drive. It is not recommended to operate machinery or drive vehicles if you experience lightheadedness, weakness, or exhaustion.
Side effects:
Common: Shortness of breath, nausea, vomiting, fatigue, dyspepsia, loss of appetite, dizziness, diarrhoea, headache.
Ibyra 150mg Tablet can lower blood cell counts, thus it's best to get blood tests done at regular intervals.
Stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside.
Ibyra 150mg Tablet should not be stopped without first talking to your doctor.
Stay away from grapefruit juice as it may raise your blood levels of the drug.
It is recommended to inform your doctor about other anticancer drugs you have been taking.
Maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhoea and other gastrointestinal disorders.
FAQs:
Can Ibyra 150mg Tablet be taken during pregnancy or breastfeeding?
Ibyra 150mg Tablet may harm an unborn baby and should not be used during pregnancy. It is also not recommended while breastfeeding, as it may pass into breast milk and harm the nursing infant.
What are Ibyra 150mg Tablet's typical side effects?
Nausea, vomiting, lethargy, diarrhoea, appetite loss, and blood cell count abnormalities are typical adverse effects.
Are there any dietary restrictions I need to follow while on Ibyra 150mg Tablet?
There are no specific dietary restrictions associated with Ibyra 150mg Tablet. However, it's essential to maintain a healthy and balanced diet to support your overall well-being during treatment. It is recommended to avoid grape juice as it increases the blood drug concentration.
Is Ibyra 150mg Tablet used as a standalone treatment in cancers?
Ibyra 150mg Tablet is usually indicated as maintenance therapy after a person completes a platinum-based chemotherapy regimen for ovarian cancer. However, newer studies are evaluating its solitary efficacy in treating different types of cancers.
Can I drive or operate machinery while taking Ibyra 150mg Tablet?
Ibyra 150mg Tablet may cause side effects such as dizziness or fatigue, which could impair your ability to drive or operate machinery safely. If you're unsure, it's best to consult with your healthcare provider for personalized advice based on your specific situation.
